Membrane IgM of bovine lymphocytes.

PubWeight™: 0.76‹?›

🔗 View Article (PMID 7112911)

Published in Vet Immunol Immunopathol on May 01, 1982

Authors

I Davidson, H Ungar-Waron, S Katzav, J Haimovich, Z Trainin

Articles by these authors

Cloning, expression, and transcriptional properties of the human enhancer factor TEF-1. Cell (1991) 3.71

Human TAFII30 is present in a distinct TFIID complex and is required for transcriptional activation by the estrogen receptor. Cell (1994) 3.46

Cell-type specific protein binding to the enhancer of simian virus 40 in nuclear extracts. Nature (1986) 3.25

Tyrosine phosphorylation of vav proto-oncogene product containing SH2 domain and transcription factor motifs. Nature (1992) 3.02

Characterization of productive and sterile transcripts from the immunoglobulin heavy-chain locus: processing of micron and muS mRNA. Mol Cell Biol (1983) 3.00

Distinct TFIID complexes mediate the effect of different transcriptional activators. EMBO J (1993) 2.66

Mode of regulation of immunoglobulin mu- and delta-chain expression varies during B-lymphocyte maturation. Cell (1984) 2.53

In vitro binding of cell-specific and ubiquitous nuclear proteins to the octamer motif of the SV40 enhancer and related motifs present in other promoters and enhancers. EMBO J (1987) 2.53

Essential role of microphthalmia transcription factor for DNA replication, mitosis and genomic stability in melanoma. Oncogene (2011) 2.49

Abrogation of metastatic properties of tumour cells by de novo expression of H-2K antigens following H-2 gene transfection. Nature (1985) 2.48

Purification of antibodies with immunoadsorbents prepared using bromoacetyl cellulose. Immunochemistry (1967) 2.35

In vitro binding of several cell-specific and ubiquitous nuclear proteins to the GT-I motif of the SV40 enhancer. Genes Dev (1987) 2.27

Tyrosine kinase-stimulated guanine nucleotide exchange activity of Vav in T cell activation. Science (1993) 2.10

One cell-specific and three ubiquitous nuclear proteins bind in vitro to overlapping motifs in the domain B1 of the SV40 enhancer. EMBO J (1987) 2.04

Subclinical lead exposure in philadelphia schoolchildren. Identification by dentine lead analysis. N Engl J Med (1974) 2.00

The monoclonality of human B-cell lymphomas. J Exp Med (1977) 1.97

Late arrest of spermiogenesis and germ cell apoptosis in mice lacking the TBP-like TLF/TRF2 gene. Mol Cell (2001) 1.94

Expanded polyglutamine stretches interact with TAFII130, interfering with CREB-dependent transcription. Nat Genet (2000) 1.92

Cloning of ALL-1, the locus involved in leukemias with the t(4;11)(q21;q23), t(9;11)(p22;q23), and t(11;19)(q23;p13) chromosome translocations. Cancer Res (1991) 1.88

A functional T-cell receptor signaling pathway is required for p95vav activity. Mol Cell Biol (1995) 1.88

The role of peptide metabolism in the growth of Listeria monocytogenes ATCC 23074 at high osmolarity. Microbiology (1995) 1.85

Perturbation of anion balance during inhibition of growth of Escherichia coli by weak acids. J Bacteriol (1998) 1.84

All six GC-motifs of the SV40 early upstream element contribute to promoter activity in vivo and in vitro. EMBO J (1985) 1.84

Transcriptional enhancer factor (TEF)-1 and its cell-specific co-activator activate human papillomavirus-16 E6 and E7 oncogene transcription in keratinocytes and cervical carcinoma cells. EMBO J (1992) 1.76

Cloning and characterization of hTAFII18, hTAFII20 and hTAFII28: three subunits of the human transcription factor TFIID. EMBO J (1995) 1.76

Transcriptional activation by simian virus 40 large T antigen: interactions with multiple components of the transcription complex. Mol Cell Biol (1993) 1.73

Immunological studies of plant hormones. Detection and estimation by immunological assays. Eur J Biochem (1971) 1.68

Characterization of the transcription activation function and the DNA binding domain of transcriptional enhancer factor-1. EMBO J (1993) 1.68

Human TAF(II)28 and TAF(II)18 interact through a histone fold encoded by atypical evolutionary conserved motifs also found in the SPT3 family. Cell (1998) 1.63

Characterization of a carcinogen-induced murine B lymphocyte cell line of C3H/eB origin. Eur J Immunol (1977) 1.60

Bronchodilatation and the site of airway resistance in severe chronic bronchitis. Thorax (1979) 1.60

Distinct domains of hTAFII100 are required for functional interaction with transcription factor TFIIF beta (RAP30) and incorporation into the TFIID complex. EMBO J (1996) 1.59

The histone fold is a key structural motif of transcription factor TFIID. Trends Biochem Sci (2001) 1.48

Human TAF(II)135 potentiates transcriptional activation by the AF-2s of the retinoic acid, vitamin D3, and thyroid hormone receptors in mammalian cells. Genes Dev (1997) 1.47

Chromatin-dependent cooperativity between constitutive and inducible activation domains in CREB. Mol Cell Biol (2001) 1.46

The human TFIID components TAF(II)135 and TAF(II)20 and the yeast SAGA components ADA1 and TAF(II)68 heterodimerize to form histone-like pairs. Mol Cell Biol (2000) 1.45

Monoclonal anti-idiotype antibodies against the murine B cell lymphoma 38C13: characterization and use as probes for the biology of the tumor in vivo and in vitro. Hybridoma (1985) 1.43

The TFIID components human TAF(II)140 and Drosophila BIP2 (TAF(II)155) are novel metazoan homologues of yeast TAF(II)47 containing a histone fold and a PHD finger. Mol Cell Biol (2001) 1.41

TONDU (TDU), a novel human protein related to the product of vestigial (vg) gene of Drosophila melanogaster interacts with vertebrate TEF factors and substitutes for Vg function in wing formation. Development (1999) 1.41

Altered subjective appetite parameters in Crohn's disease patients. Clin Nutr (2001) 1.41

A novel family of developmentally regulated mammalian transcription factors containing the TEA/ATTS DNA binding domain. J Biol Chem (1996) 1.38

Histone folds mediate selective heterodimerization of yeast TAF(II)25 with TFIID components yTAF(II)47 and yTAF(II)65 and with SAGA component ySPT7. Mol Cell Biol (2001) 1.38

The N-terminal domain of the human TATA-binding protein plays a role in transcription from TATA-containing RNA polymerase II and III promoters. EMBO J (1994) 1.37

Different TBP-associated factors are required for mediating the stimulation of transcription in vitro by the acidic transactivator GAL-VP16 and the two nonacidic activation functions of the estrogen receptor. Nucleic Acids Res (1993) 1.37

Differential expression of H-2 gene products in tumour cells in associated with their metastatogenic properties. Nature (1980) 1.35

Anesthetic drugs accelerate the progression of postoperative metastases of mouse tumors. J Clin Invest (1981) 1.34

Anti-penicilloyl antibodies: detection with penicilloylated bacteriophage and isolation with a specific immunoadsorbent. Nature (1967) 1.34

The SV40 TC-II(kappa B) enhanson binds ubiquitous and cell type specifically inducible nuclear proteins from lymphoid and non-lymphoid cell lines. EMBO J (1989) 1.34

Antibodies elicited with conjugates of nucleosides with synthetic polypeptides. Biochim Biophys Acta (1967) 1.34

Differential expression of the TEF family of transcription factors in the murine placenta and during differentiation of primary human trophoblasts in vitro. Dev Dyn (1998) 1.32

Human TAF(II28) promotes transcriptional stimulation by activation function 2 of the retinoid X receptors. EMBO J (1996) 1.28

Rabies virus detection by RT-PCR in decomposed naturally infected brains. Vet Microbiol (2002) 1.27

Peripheral neural representation of spatial dimensions of a textured surface moving across the monkey's finger pad. J Physiol (1980) 1.27

The SV40 TC-II(kappa B) and the related H-2Kb enhansons exhibit different cell type specific and inducible proto-enhancer activities, but the SV40 core sequence and the AP-2 binding site have no enhanson properties. EMBO J (1989) 1.26

Affinity labeling of the heavy and light chains of a myeloma protein with anti-2,4-dinitrophenyl activity. Proc Natl Acad Sci U S A (1970) 1.20

Multiple interactions between hTAFII55 and other TFIID subunits. Requirements for the formation of stable ternary complexes between hTAFII55 and the TATA-binding protein. J Biol Chem (1996) 1.20

Global transcription regulators of eukaryotes. Cell (1999) 1.19

Localization of affinity-labeled residues on the heavy and light chain of two myeloma proteins with anti-hapten activity. Biochemistry (1972) 1.17

Expression of an immediate early polypeptide and activation of a viral origin of DNA replication in cells containing a fragment of herpes simplex virus DNA. Virology (1985) 1.16

Sequence-specific transactivators counteract topoisomerase II-mediated inhibition of in vitro transcription by RNA polymerases I and II. Nucleic Acids Res (1993) 1.16

trans activation by the full-length E2 proteins of human papillomavirus type 16 and bovine papillomavirus type 1 in vitro and in vivo: cooperation with activation domains of cellular transcription factors. J Virol (1994) 1.13

Antibdies of different specificities in normal rabbit sera. J Immunol (1970) 1.13

Antigen- and ionophore-induced signal transduction in rat basophilic leukemia cells involves protein tyrosine phosphorylation. J Biol Chem (1991) 1.12

Activation of Ras in vitro and in intact fibroblasts by the Vav guanine nucleotide exchange protein. Mol Cell Biol (1994) 1.12

Suicide as an indicator of mental health. BMJ (1994) 1.10

In vitro induction of a primary response to the dinitrophenyl determinant. J Exp Med (1970) 1.10

Reaction of anti-idiotypic antibody with the hapten-binding site of a myeloma protein. Proc Natl Acad Sci U S A (1971) 1.09

Suppression of the humoral antibody response in natural retrovirus infections. Science (1983) 1.08

Inactivation of poly-DL-alanyl bacteriophage T4 with antisera specific toward poly-DL-alanine. J Immunol (1966) 1.07

Specific blocking in vitro of antibody synthesis by affinity labelling reagents. Nature (1969) 1.06

The transactivation domain of adenovirus E1A interacts with the C terminus of human TAF(II)135. J Virol (1997) 1.06

B lymphocytes contain three species of mu chains. Eur J Immunol (1978) 1.04

Synergistic transcriptional activation by TATA-binding protein and hTAFII28 requires specific amino acids of the hTAFII28 histone fold. Mol Cell Biol (1999) 1.04

Transcription factor TEAD4 regulates expression of myogenin and the unfolded protein response genes during C2C12 cell differentiation. Cell Death Differ (2011) 1.04

Nucleoside-specific antibodies elicited by synthetic antigens. Fed Proc (1966) 1.04

MEQ and V-IL8: cellular genes in disguise? Acta Virol (2000) 1.03

Degradation of secretory immunoglobulin M in B lymphocytes occurs in a postendoplasmic reticulum compartment and is mediated by a cysteine protease. J Biol Chem (1992) 1.03

Antigen specific T-cell helper factor cross reacts idiotypically with antibodies of the same specificity. Nature (1979) 1.01

Understanding the dialysis access steal syndrome. A review of the etiologies, diagnosis, prevention and treatment strategies. J Vasc Access (2008) 1.00

Metastatic properties conferred on nonmetastatic tumors by hybridization of spleen B-lymphocytes with plasmacytoma cells. J Natl Cancer Inst (1981) 0.99

Cross-reactive idiotypic determinants on murine anti-(T,G)-A--L antibodies. J Immunol (1978) 0.99

Human TAF(II)28 interacts with the human T cell leukemia virus type I Tax transactivator and promotes its transcriptional activity. Proc Natl Acad Sci U S A (1997) 0.99

Affinity labeling and cross-linking of the heavy and light chains of a myeloma protein with anti-2,4-dinitrophenyl activity. Biochemistry (1971) 0.99

The implication of BLV infection in the productivity, reproductive capacity and survival rate of a dairy cow. Vet Immunol Immunopathol (1989) 0.98

Inactivation of bacteriophage T4, of poly-D-alanyl bacteriophage and of penicilloyl bacteriophage by immunospecifically isolated IgM and IgG antibodies. J Immunol (1969) 0.98

Functional interplay between platelet activation and endothelial dysfunction in patients with coronary heart disease. Platelets (2006) 0.97

N-terminal amino acid sequence identity between a major allergen of Ascaris lumbricoides and Ascaris suum, and MHC-restricted IgE responses to it. Immunology (1990) 0.97

Alterations in major histocompatibility complex phenotypes of mouse cloned T10 sarcoma cells: association with shifts from nonmetastatic to metastatic cells. J Natl Cancer Inst (1983) 0.97

Ecology of leishmaniasis in the south of France. 20. Dispersal of Phlebotomus ariasi Tonnoir, 1921 as a factor in the spread of visceral leishmaniasis in the Cévennes. Ann Parasitol Hum Comp (1984) 0.97

Human TEF-5 is preferentially expressed in placenta and binds to multiple functional elements of the human chorionic somatomammotropin-B gene enhancer. J Biol Chem (1997) 0.95

Cell surface components of carcinogen-induced lymphoid tumors in SJL/J mice. Eur J Immunol (1977) 0.94

Coordinate regulation of RARgamma2, TBP, and TAFII135 by targeted proteolysis during retinoic acid-induced differentiation of F9 embryonal carcinoma cells. BMC Mol Biol (2001) 0.94

Antigen binding and idiotypic properties of reconstituted immunoglobulins G derived from homogeneous rabbit anti-pneumococcal antibodies. Eur J Immunol (1975) 0.94

The role of herbicides in the erosion of salt marshes in eastern England. Environ Pollut (2003) 0.93

Studies of neonatal calf diarrhoea. II. Serum and faecal immune globulins in enteric colibacillosis. Br Vet J (1975) 0.93

The TATA-binding protein and its associated factors are differentially expressed in adult mouse tissues. J Biol Chem (1999) 0.93

Interaction between T antigen and TEA domain of the factor TEF-1 derepresses simian virus 40 late promoter in vitro: identification of T-antigen domains important for transcription control. J Virol (1996) 0.92

Immunological cross-reactivity of antibodies to a synthetic undecapeptide analogous to the amino terminal segment of carcinoembryonic antigen, with the intact protein and with human sera. Proc Natl Acad Sci U S A (1976) 0.92

Complete amino acid sequences of five dimeric and four monomeric forms of metallothionein from the edible mussel Mytilus edulis. Eur J Biochem (1993) 0.91